Notizie AIOM – anno XV – Pagina 56

13 Giugno 2017

FDA Requests Removal of Oxymorphone Hydrochloride for Risks Related to Abuse

June 9, 2017 - On June 8,the U.S. Food and Drug Administration (FDA) requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated oxymorphone hydrochloride, from the market. After careful consideration, the agency is seeking removal based on its concern ...
Leggi tutto

13 Giugno 2017

Everolimus-induced pneumonitis associates with favourable outcome in patients with metastatic renal cell carcinoma

Mammalian target of rapamycin inhibitors may induce pneumonitis. We analysed the association of pneumonitis with outcomes in everolimus treated metastatic renal cell carcinoma (mRCC) patients. Eighty-five mRCC patients received everolimus at Helsinki University Hospital ...
Leggi tutto

13 Giugno 2017

CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial

CT-P6 is a proposed biosimilar to reference trastuzumab. In this study, we aimed to establish equivalence of CT-P6 to reference trastuzumab in neoadjuvant treatment of HER2-positive early-stage breast cancer. In this randomised, double-blind, active-controlled, phase 3 equivalence ...
Leggi tutto

13 Giugno 2017

Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer

Alectinib, a highly selective inhibitor of anaplastic lymphoma kinase (ALK), has shown systemic and central nervous system (CNS) efficacy in the treatment of ALK-positive non-small-cell lung cancer (NSCLC). We investigated alectinib as compared with crizotinib in patients ...
Leggi tutto

12 Giugno 2017

European Commission Approves Nivolumab for Previously Treated, Locally Advanced, Unresectable or Metastatic Urothelial Cancer

June 8, 2017 - On June 2, the European Commission (EC) approved nivolumab for the treatment of locally advanced unresectable or metastatic urothelial carcinoma in adults after failure of prior platinum-containing therapy. This makes nivolumab the first immuno-oncology agent ...
Leggi tutto

12 Giugno 2017

9 giugno 2017 – Per la lotta al cancro non solo farmaci innovativi, ma anche prevenzione, informazione e diagnosi precoce

12 Giugno 2017

9 giugno 2017 – Comunicazione EMA su docetaxel

12 Giugno 2017

7 giugno 2017 – Determinazione AIFA n° 1023/2017

12 Giugno 2017

ASCO Congratulates NIH Director Francis Collins on Remaining in Critical Leadership Position

June 8, 2017 - ASCO President Bruce E. Johnson, MD, FASCO, released the following statement today: “ASCO congratulates Francis S. Collins, MD, PhD, on the announcement of his continued service as the Director of the National Institutes of Health (NIH). A renowned researcher ...
Leggi tutto

8 Giugno 2017

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

Sentinel-lymph-node biopsy is associated with increased melanoma-specific survival (i.e., survival until death from melanoma) among patients with node-positive intermediate-thickness melanomas (1.2 to 3.5 mm). The value of completion lymph-node dissection for patients with ...
Leggi tutto

LAVORIAMO CON

News

FUMO: “IN 4 ANNI RADDOPPIATO L’USO DI SIGARETTE ELETTRONICHE E TABACCO RISCALDATO. GIÀ 40.000 CITTADINI HANNO FIRMATO PER AUMENTARE DI 5 EURO IL COSTO DEI PRODOTTI DA FUMO”

TUMORE DELLA PROSTATA: AIFA APPROVA DAROLUTAMIDE PIÙ TERAPIA DI DEPRIVAZIONE ADROGENICA. MIGLIORA IL CONTROLLO DELLA MALATTIA E LA QUALITÀ DI VITA

LA PREVENZIONE DEL MELANOMA: AL VIA UNA CAMPAGNA NEI COOP.FI

TUMORI: “AIFA APPROVA LA FORMULAZIONE SOTTOCUTANEA E TRE NUOVE INDICAZIONI TERAPEUTICHE DI NIVOLUMAB”

TUMORE AL SENO: METASTASI SI DIFFONDONO COME GOCCE SU UNA SUPERFICIE. LA CAPACITÀ INVASIVA DIPENDE DALLA “FLUIDITÀ” DEL CANCRO

ONE HEALTH FOUNDATION: AL VIA IL PROGETTO IN 36 CENTRI ESTIVI IN ALBANIA. SULLA “NAVE DELLA SALUTE” SVOLTI PIU’ DI 550 TEST E VISITE MEDICHE

AL VIA LA TERZA EDIZIONE DELLA “NAVE DELLA SALUTE” ITALIA-ALBANIA. LA PREVENZIONE SALE A BORDO CON 17 MEDICI SPECIALISTI E 10 AMBULATORI

Notizie AIOM – anno XV

FDA Requests Removal of Oxymorphone Hydrochloride for Risks Related to Abuse

Everolimus-induced pneumonitis associates with favourable outcome in patients with metastatic renal cell carcinoma

CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial

Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer

European Commission Approves Nivolumab for Previously Treated, Locally Advanced, Unresectable or Metastatic Urothelial Cancer

9 giugno 2017 – Per la lotta al cancro non solo farmaci innovativi, ma anche prevenzione, informazione e diagnosi precoce

9 giugno 2017 – Comunicazione EMA su docetaxel

7 giugno 2017 – Determinazione AIFA n° 1023/2017

ASCO Congratulates NIH Director Francis Collins on Remaining in Critical Leadership Position

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma